SCHEMBL22022912

SCHEMBL22022912

O=C(Cc1ccc(Oc2ccccc2)cc1)Nc1cc2ccccc2cc1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.57
▸ KDM4E B2RXH2 4/20 0.57
▸ PKM P14618 1/20 0.57
▸ GAA P10253 2/20 0.56
▸ PTPN1 P18031 1/20 0.54
▸ ABCC1 P33527 1/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ LMNA P02545 1/20 0.49
▸ MAPT P10636 1/20 0.48
▸ GFER P55789 1/20 0.48
▸ NGLY1 Q96IV0 1/20 0.48
▸ GLS O94925 1/20 0.47
▸ EPHX2 P34913 3/20 0.47
▸ LTA4H P09960 2/20 0.47
▸ CASP3 P42574 1/20 0.47
▸ SENP8 Q96LD8 1/20 0.47
▸ SENP7 Q9BQF6 1/20 0.47
▸ SENP6 Q9GZR1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19512045 0.90 POLB (0.55) ALDH1A1KDM4EPKMGAAPTPN1
SCHEMBL22022878 0.86 ACLY (0.60) ALDH1A1KDM4EPKMPTPN1ABCC1
SCHEMBL2271181 0.85 GAA (0.60) ALDH1A1KDM4EPKMGAAMEN1
SCHEMBL9079780 0.85 KDM4E (0.67) ALDH1A1KDM4EPKMGAAMEN1
SCHEMBL5696409 0.85 ALDH1A1 (0.63) ALDH1A1KDM4EPKMGAAMEN1
SCHEMBL9082681 0.85 MEN1 (0.57) ALDH1A1KDM4EPKMGAAMEN1
SCHEMBL22022887 0.84 MEN1 (0.76) ALDH1A1KDM4EPKMGAAMEN1
SCHEMBL6407408 0.84 MEN1 (0.66) ALDH1A1KDM4EPKMGAAMEN1
SCHEMBL22022937 0.83 HCAR2 (0.56) ALDH1A1KDM4EPKMPTPN1ABCC1
SCHEMBL22022895 0.83 ACLY (0.53) ALDH1A1KDM4EPKMPTPN1ABCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220054438-A1 KCHIP2 MODULATOR COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) 2022-02-24 — — US disclosed
US-20220054438-A1 KCHIP2 MODULATOR COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) 2022-02-24 — — US disclosed
EP-3890734-A1 KCHIP2 MODULATOR COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2021-10-13 — — EP disclosed
WO-2020115019-A1 KCHIP2 MODULATOR COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) 2020-06-11 — — WO disclosed
EP-3662908-A1 MODULATING COMPOUNDS OF KCHIP2 AND ITS USE FOR THE TREATMENT OF CARDIOVASCULAR PATHOLOGIES Consejo Superior de Investigaciones Cientificas (CSIC) (ES) 2020-06-10 — — EP disclosed
EP-3662908-A1 MODULATING COMPOUNDS OF KCHIP2 AND ITS USE FOR THE TREATMENT OF CARDIOVASCULAR PATHOLOGIES Consejo Superior de Investigaciones Cientificas (CSIC) (ES) 2020-06-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220054438-A1 KCHIP2 MODULATOR COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CARDIOVASCULAR DISEASES KCNK2, KCNT2, KCNT1 ALDH1A1 3537/4885KDM4E 967/4885PKM 343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback